Francois A, Chatikhine V A, Chevallier B, Ren G S, Berry M, Chevrier A, Delpech B
Department of Pathology, Centre Henri-Becquerel, Rouen, France.
Am J Clin Oncol. 1995 Apr;18(2):133-8. doi: 10.1097/00000421-199504000-00008.
One case of breast neuroendocrine primary small cell carcinoma with light microscopic and immunohistochemical findings is reported. The patient died of unrelated disease 21 months after diagnosis and treatment by modified radical mastectomy, radiotherapy and subsequent chemotherapy. Immunohistochemical studies revealed cytokeratin and neuroendocrine markers (chromogranin, neuron-specific enolase) immunostaining on tumoral cells. Expression for neuropeptides (met-enkephalin, leu-enkephalin, beta-endorphin) and CALLA antigen was found. Based on this case report and six other previously reported cases, breast neuroendocrine primary small cell carcinoma appears to be a very aggressive tumor for which no firm conclusions regarding treatment can be drawn.
报告了一例具有光镜和免疫组化结果的乳腺神经内分泌原发性小细胞癌。该患者在接受改良根治性乳房切除术、放疗及后续化疗诊断和治疗21个月后死于无关疾病。免疫组化研究显示肿瘤细胞上细胞角蛋白和神经内分泌标志物(嗜铬粒蛋白、神经元特异性烯醇化酶)免疫染色阳性。发现了神经肽(甲硫氨酸脑啡肽、亮氨酸脑啡肽、β-内啡肽)和CALLA抗原的表达。基于本病例报告及其他6例先前报告的病例,乳腺神经内分泌原发性小细胞癌似乎是一种侵袭性很强的肿瘤,关于其治疗尚无确凿结论。